Hill Brian T - Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH 44195, USA. hillb2@ccf.org

基本信息

浏览量：149

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 461 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Evaluation of clinical parameters and biomarkers in older, untreated mantle cell lymphoma patients receiving bendamustine-rituximab

Colleen A Ramsower,Allison Rosenthal, Ryan S Robetorye,Raphael Mwangi,Matthew Maurer,Diego Villa, Tim McDonnell,Andrew Feldman,Jonathon B Cohen,Thomas Habermann,Elias Campo,Guillem Clot,

British journal of haematology (2023)

引用0浏览0WOS引用

Impact of active surveillance at time of diagnosis on overall survival in nodular lymphocyte-predominant Hodgkin lymphoma: A National Cancer Database study

Victoria M Rogness,Wei Wei,Matthew Cortese,Brian T Hill

Leukemia research (2023): 107402

引用0浏览0WOS引用

Five-year follow-up of ZUMA-1 supports the curative potential of axicabtagene ciloleucel in refractory large B-cell lymphoma

Sattva S. Neelapu,Caron A. Jacobson,Armin Ghobadi,David B. Miklos,Lazaros J. Lekakis,Olalekan O. Oluwole,Yi Lin, Ira Braunschweig,Brian T. Hill, John M. Timmerman,Abhinav Deol, Patrick M. Reagan,

Blood（2023）

引用0浏览0引用

High Grade B-Cell Lymphoma: Pathologic Classification and Treatment Recommendations

Brian T. Hill,Sarah L. Ondrejka

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2023): S54-S56

引用0浏览0引用

A Multicenter Analysis of the Outcomes with Venetoclax in Patients with Relapsed Mantle Cell Lymphoma

Yazeed Sawalha,Subir Goyal,Jeffrey M Switchenko,Jason T Romancik,Manali Kamdar,Irl Brian Greenwell,Brian T Hess,Krista M Isaac,Craig A Portell,Alex V Mejia Garcia,Scott R Goldsmith,Natalie S Grover,

Blood Adv（2023）

引用0浏览0WOS引用

Phase 2 trial of umbralisib, ublituximab, and venetoclax in patients with relapsed/refractory mantle cell lymphoma

Danielle S Wallace, Chris Rowland,Brian T Hill,Andrea M Baran,Carla Casulo,Patrick M Reagan, Allison Winter,Reem Karmali,Jane N Winter,Leo I Gordon, Andrew Bui,Peter Sportelli,

Leukemia & lymphoma（2023）

引用0浏览0WOS引用

Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation (AHCT) for Hodgkin (HL) and Non-Hodgkin Lymphoma (NHL): Secondary Analysis from Two Multicenter Randomized Controlled Trials (RCT) of Hematopoietic Cell Transplant Survivorship Interventions

Agrima Mian,Wei Wei,Rajshekhar Chakraborty, Jean Yi, Jaime M. Preussler,Brian T. Hill,Jan Cerny,Abhinav Deol,Theresa E. Hahn,Shahrukh K. Hashmi, Samantha Jaglowski,Heather S.L. Jim,

Transplantation and Cellular Therapyno. 2 (2023): S369-S370

引用0浏览0引用

Outcomes of limited stage primary bone diffuse large B-cell lymphoma in the rituximab era: a multicenter, retrospective study

Alexandra Rezazadeh,Aniko Szabo,Arushi Khurana,David J Inwards,Matthew A Lunning,Nancy L Bartlett,Paolo F Caimi,Thomas D Rodgers,Paul M Barr,Sayan Mullick Chowdhury,Narendranath Epperla, Hiruni Mendries,

Haematologica (2023)

引用0浏览0WOS引用

Treatment Outcomes and Roles of Transplantation and Maintenance Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma: Results From Large Real-World Cohorts

Peter Martin,Jonathon B Cohen,Michael Wang,Anita Kumar,Brian Hill,Diego Villa,Jeffrey M Switchenko,Brad Kahl,Kami Maddocks,Natalie S Grover,Keqin Qi,Lori Parisi,

J Clin Oncol（2023）

引用12浏览0WOS引用

Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study

Michael Wang,Javier Munoz,Andre Goy,Frederick L Locke,Caron A Jacobson,Brian T Hill, John M Timmerman,Houston Holmes,Samantha Jaglowski,Ian W Flinn, Peter A McSweeney,David B Miklos,

J Clin Oncol（2023）

引用28浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn